RT 02-03 JJ07 main web - Respiratory Therapy Website

market leaders in their respective healthcare segments. Ed has
proven himself to be an outstanding leader who delivers on his
commitments in product development, sales and marketing and
operational and financial performance. His early career included
key leadership roles in sales and marketing. Most importantly,
he has demonstrated his ability to build winning teams,
integrate the best of all ideas and empower people of all levels.”
CASTING A WIDER WEB
Draeger Medical introduces a comprehensive, web-based
information management solution that integrates vital OR,
PACU and ICU patient information from medical devices and
systems across the Acute Point of Care (APOC). Innovian
Solution Suite streamlines access to patient information by
providing one platform for the critical and perioperative care
environments. It strengthens Draeger Medical’s suite of
information management solutions, which also includes a
distributed, client-based anesthesia information management
solution for the OR. The new web-based components of the
suite include solutions for the perioperative and critical care
environments. In the perioperative environment, Draeger
Medical’s OR/Anesthesia information management system
covers scheduling, pre-op, holding, intra-op and PACU. For
critical care there is an ICU documentation system that provides
full electronic patient charting, flowsheet, scoring and printed
reports. Working together, these solutions continually capture
vital patient information from perioperative and critical care
medical devices and clinical information systems. That data is
integrated into one, easy-to-navigate interface for direct access
by clinicians. A more accurate patient record is possible when
patient data is automatically placed into the record. With
electronic charting clinicians can spend less time writing and
have more time for patient care. Draeger Medical’s web-based
information management solutions support Pick and Go
technology. This enables information collected by Infinity
monitors during patient transfer to be automatically backfilled
into the database. Moreover, because it is built on open
standards, it fully supports HL7 interfaces to the hospital
information system. Contact draeger.com.
GET SMART
Draeger Medical, Inc announced FDA 510k clearance for its new
Infinity TeleSmart system featuring a compact device capable of
monitoring ECG and SpO 2. Infinity TeleSmart provides the
performance of a full-size patient monitor, packaged in a
compact patient-worn telemetry device for adult and pediatric
patients. Built-in ACE (Arrhythmia Classification Expert) and
pacer detection algorithms enhance ECG processing and reduce
false alarms. Infinity TeleSmart allows for viewing patient
information at the patient’s side. Unlike traditional telemetry,
Infinity TeleSmart has a color display that shows the patient’s
ECG for all monitored leads, heart rate, SpO 2, and electrode
status. It also shows patient demographics to help confirm the
patient’s identification before giving medications, taking blood
samples, or performing treatments. The TeleSmart has built-in
alarming and alarm controls, which provides alarm alerts both
at the patient’s side and the central monitoring station. The
color display helps the clinician to assess the alarms and
respond accordingly. The Infity TeleSmart also has a built-in
rechargeable battery. The battery can be recharged via a bedside
charger or at a multi-device charger at the central monitoring
station. Because Infinity TeleSmart has a built-in display and
alarms, it enables the clinical staff to be alerted to patient
conditions without having to use additional devices. Based on
the industry-standard 802.11b WiFi technology, Infinity
TeleSmart provides continuous standalone monitoring – even if
the patient moves out of the hospital’s wireless network
coverage area. The TeleSmart can be used with the OneNet
shared network and hospitals can use their industry-standard
802.11b (WiFi) access points for both telemetry and patient
monitoring. Wireless data exchange and signal integrity is
facilitated with bidirectional communication between Infinity
TeleSmart and the Infinity CentralStation.
IN THE BLOOD
RNA Medical, division of Bionostics, Inc., Devens, MA,
announces CVC 123, Calibration Verification Controls for use
with blood gas, electrolyte, and metabolite analyzers, is now
assayed for IL GEM Premier 3000, Bayer 400 Series, and
Radiometer ABL 800 Series analyzers. CVC 123 is used to
confirm the calibration and linearity of blood gas systems
measuring pH, pCO 2, pO 2, sodium, potassium, chloride, ionized
calcium, ionized magnesium, glucose, and lactate. Provided in 5
levels, it is packaged in kits containing 4 ampuls of each level.
In addition to US availability, CVC 123 is distributed in Canada
through Thermo Fisher Scientific. Contact (800) 533-6162
RNAMedical.com.
TAKING THE PULSE
Nonin Medical, Inc announced today that it has entered into an
agreement with MedAssets Supply Chain Systems, a leading US
healthcare group purchasing organization (GPO), to make its
comprehensive line of pulse oximeters and sensors, including
the only wireless oximeter based on Bluetooth technology,
available to MedAssets customers. Under the multi-year
agreement with Nonin, MedAssets customers, numbering more
than 1,500 acute care hospitals and 25,000 alternate-site
facilities nationwide, will have access to these pulse oximeters
and sensors. Minneapolis-based Nonin Medical, Inc designs,
manufactures and distributes a broad spectrum of physiological
monitoring devices, currently used by health and medical
professionals in more than 125 countries. The company draws
upon its industry-leading capabilities in signal processing and
sensor design to develop innovative pulse oximeters, sensors,
accessories and software with features not available in
competing products. MedAssets partners with healthcare
providers to improve operating margins and cash flow while
supporting quality of care goals. MedAssets implements
integrated solutions to address the greatest opportunities for
financial and process improvement and drives performance in
revenue cycle, supply chain and clinical service line
management. MedAssets is a business partner to more than
2,400 hospitals and 25,000 non-acute care healthcare providers.
For more information, go to medassets.com.
UPGRADED
A software upgrade (Version 5) to the Nova Biomedical Stat
Profile Critical Care Xpress analyzer provides the reporting of
estimated Glomerular Filtration Rate (eGFR) with every serum
creatinine measurement. eGFR is a calculated test that
considers the effects of age, sex, and body weight on creatinine
generation, thereby adjusting serum creatinine values to more
accurately reflect creatinine clearance. An eGFR calculated
from serum creatinine is a practical way to detect, evaluate, and
manage people with chronic kidney disease (CKD), especially
people with risk factors for CKD—diabetes, hypertension,
cardiovascular disease, or family history of kidney disease—in
whom CKD might otherwise go undetected and untreated. Stat
16 Respiratory Therapy Vol. 2 No. 3 � June-July 2007